Cosmos Pharmaceutical Co., Ltd.
Drug Stores & Pharmacies · Japan · 5,101 Employees
View Company Info for Free
About
Headquarters
2 Chome-10-1 Daiichi Fukuoka Building S Buildin...Phone Number
+81 924330660Website
www.cosmospc.co.jpRevenue
$6.5 BillionStock Symbol
3349Industry
Who is Cosmos Pharmaceutical Co., Ltd.
Cosmo is a specialty pharmaceutical company focused on developing and commercialising products to treat selected gastrointestinal disorders and improve endoscopy quality measures through aiding the detection of colonic lesions. Cosmo has also developed medical devices for endoscopy and has a partnership with Medtronic for the global distribution of GI Genius(TM) its artificial intelligence device that uses artificial intelligence to help detect potential signs of colon cancer. Cosmo has licensed Aemcolo(R) to Red Hill Biopharma Ltd. for the US and has licensed Relafalk(R) to Dr. Falk Gmbh for the EU and other countries.Read more
Cosmos Pharmaceutical Co., Ltd. Org Chart
Is Cosmos Pharmaceutical Co., Ltd. your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Cosmos Pharmaceutical Co., Ltd. is spiking on competitors!
Cosmos Pharmaceutical Co., Ltd., which may be a good buyer, showed buying intent in Masked Content Topic
Check if Cosmos Pharmaceutical Co., Ltd. has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Cosmos Pharmaceutical Co., Ltd. has new funding data
Congratulate Masked Content for being promoted to Masked Content at Cosmos Pharmaceutical Co., Ltd.
Product Launch: Get notified when Cosmos Pharmaceutical Co., Ltd. launches new products
Earning: See what the market has to say on Cosmos Pharmaceutical Co., Ltd. recently announced quarterly report
Website visits: Recent activity has been detected on your website
Click to see if Cosmos Pharmaceutical Co., Ltd. had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Cosmos Pharmaceutical Co., Ltd.
Find more new buyers
Cosmos Pharmaceutical Co., Ltd. Employee Growth Rate
View Cosmos Pharmaceutical Co., Ltd.’s full employee growth data
Percentage of growth
1st year Mask
2nd year Mask
Cosmos Pharmaceutical Co., Ltd. Tech Stack
A closer look at the technologies used by Cosmos Pharmaceutical Co., Ltd.
Most Recent Scoops
Last Week
Hot Scoop - Business
Last month
Hot Scoop - Financial
Last month
Hot Scoop - Opportunities
Cosmos Pharmaceutical Co., Ltd. News & Media
15 Largest Pharmacy Chains in the World
In this article, we will be analyzing the global pharmacy industry and its dominant players, while covering the 15 largest pharmacy chains in the world. If you wish to skip our detailed analysis, you can move directly to the 5 Largest Pharmacy Chains in the World. The Global Pharmaceutical Industry to Reach $1.8 Trillion According […]
COSMO Technologies secures funding and announces new product launches
DENVER, June 23, 2021 /PRNewswire/ -- COSMO Technologies, Inc., a first-of-its-kind family technology design and manufacturing company, announced today the closing of its Pre-Seed funding round. The funds will be used to accelerate development of COSMO's suite of family products, expand...Acacia Pharma Announces Early Repayment of Loan Facility from Hercules Technology Growth Capital and Reduction in Debt Service Obligations
THIS ANNOUNCEMENT CONTAINS REGULATED INFORMATION. THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION Acacia Pharma Announces Early Repayment of Loan Facility from Hercules Technology Growth Capital Reduction in Debt Service Obligations Cambridge, UK and Indianapolis, US – 4 May 2021, 07:00 CEST: Acacia Pharma Group plc (“Acacia Pharma”, the “Group” or the “Company”) (EURONEXT: ACPH), a hospital pharmaceutical company focused on the development and commercialization of new products aimed at improvingInvitation to Cosmo's GI Genius™ Q&A session for investors, analysts and journalist
DUBLIN, April 28, 2021 /PRNewswire/ -- Cosmo Pharmaceuticals N.V. (SIX: COPN) ( XETRA: C43) invites investors, financial analysts as well as business and trade media to a conference call Q&A session on the 4th of May 2021 to discuss GI Genius™, the first device approved by the US Food and...Cosmo announces FDA approval of GI Genius™ intelligent endoscopy module, its revolutionary Artificial Intelligence device for lesion detection during colonoscopy
DUBLIN, April 12, 2021 /PRNewswire/ -- Cosmo Pharmaceuticals NV (SIX: COPN) today announced the FDA approval of GI Genius™ intelligent endoscopy system, its revolutionary device for lesion detection during colonoscopy. The GI Genius module FDA approval marks a pivotal milestone for Cosmo...
Read more news
Frequently Asked Questions Regarding Cosmos Pharmaceutical Co., Ltd.
Cosmo is a specialty pharmaceutical company focused on developing and commercialising products to treat selected gastrointestinal disorders and improve endoscopy quality measures through aiding the detection of colonic lesions. Cosmo has also developed medical devices for endoscopy and has a partnership with Medtronic for the global distribution of... Read More
